22157.jpg
Global Infectious Disease Diagnostics Market Report 2022-2032: Shift in Focus from Centralized Laboratories to Decentralized POC Testing Bolsters Growth
June 29, 2023 04:03 ET | Research and Markets
Dublin, June 29, 2023 (GLOBE NEWSWIRE) -- The "Infectious Disease Diagnostics Market Report 2022-2032" report has been added to ResearchAndMarkets.com's offering.Growing Prevalence of Infectious...
Global Infection Surveillance Solutions Market
Global Infection Surveillance Solutions Market 2023 - 2030: Increasing Adoption of Inorganic Growth Strategies Fuels the Sector
April 19, 2023 10:33 ET | Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User (Hospitals, Clinics, Ambulatory Surgical Center,...
Global Market for Infection Surveillance Solutions
Global Infection Surveillance Solutions Markets, 2020-2021 & 2022-2026: Growing Number of HAIs, Continuing Advancements and Innovations and More Expenditure on Healthcare Driving Growth
April 05, 2022 07:38 ET | Research and Markets
Dublin, April 05, 2022 (GLOBE NEWSWIRE) -- The "Infection Surveillance Solutions - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
22157.jpg
U.S. Infection Prevention and Control (IPC) in Outpatient Care Facilities: COVID-19 Pandemic, Healthcare Staff Shortage and Digital Tools Boost IPC Solution Adoption
February 25, 2022 06:38 ET | Research and Markets
Dublin, Feb. 25, 2022 (GLOBE NEWSWIRE) -- The "United States Infection Prevention and Control (IPC) in Outpatient Care Facilities Growth Opportunities" report has been added to...
22157.jpg
Global Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products Market Report to 2026 - Featuring Gilead Sciences, Merck and Novartis Among Others
July 01, 2021 04:53 ET | Research and Markets
Dublin, July 01, 2021 (GLOBE NEWSWIRE) -- The "Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products: 2021-2026" report has been added to ResearchAndMarkets.com's...
Mark Neaman Photo
EPA Approves New, Broader Pathogen Killing Claims for Applied Silver’s SilvaClean® Commercial Laundry Additive Now Used in Healthcare and Sports Medicine Programs
March 28, 2019 13:19 ET | Applied Silver Inc.
EPA Agrees SilvaClean® Kills MRSA and a Broad Range of Antibiotic-Resistant Pathogens Company Appoints Mark Neaman, former Chairman, President and CEO of NorthShore (IL) University Health Systemto...